26 Stocks Moving In Thursday's Mid-Day Session

Loading...
Loading...

Gainers

  • Dave Inc. DAVE gained 29.4% to $6.73.
  • Takung Art Co., Ltd. TKAT shares gained 18.6% to $4.1499. Traders are circulating earlier news that China is looking to separate NFTs from crypto via new blockchain infrastructure.
  • BTCS Inc. BTCS jumped 18.4% to $7.93. The company announced on January 5 its dividend would be payable in Bitcoin.
  • G Medical Innovations Holdings Ltd GMVD gained 15.8% to $3.44. McDade Products and G Medical Tests and Services, on Wednesday, announced an additional $6.5 million purchase order for 2 million COVID-19 PCR collection test kits.
  • KB Home KBH rose 12.9% to $47.83 after the company reported better-than-expected earnings for its fourth quarter on Wednesday.
  • Babylon Holdings Limited BBLN gained 12% to $6.54. Deutsche Bank, on Wednesday, initiated coverage on Babylon Holdings with a Buy rating and announced a price target of $9.
  • Sonendo, Inc. SONX jumped 9.7% to $7.88. Sonendo recently issued Q4 and FY21 sales guidance above estimates.
  • Bandwidth Inc. BAND jumped 9.1% to $71.79. Piper Sandler upgraded Bandwidth from Neutral to Overweight and announced a $102 price target.
  • Taiwan Semiconductor Manufacturing Company Limited TSM rose 8.8% to $143.80 after the company released results for its fourth quarter on Thursday. The world’s largest chipmaker said its profit surged 16.4% to $5.98 billion, helped by rising demand for semiconductors.
  • Just Eat Takeaway.com N.V. GRUB rose 8.7% to $11.07 after gaining around 4% on Wednesday.
  • Lion Group Holding Ltd. LGHL rose 8.4% to $1.42.
  • Hawaiian Holdings, Inc. HA gained 6% to $20.51. Cowen & Co. upgraded Hawaiian Holdings from Underperform to Market Perform and raised the price target from $17.5 to $23.

Check out these big penny stock gainers and losers

Losers

  • electroCore, Inc. ECOR shares fell 17.5% to $0.7264. electroCore shares jumped 64% on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for PTSD treatment.
  • Virgin Galactic Holdings, Inc. SPCE shares fell 15% to $10.52 after the company announced a proposed convertible senior notes offering.
  • Nxt-ID, Inc. NXTD shares declined 13.3% to $3.5878 after jumping over 30% on Wednesday.
  • Fresh Vine Wine, Inc. VINE fell 12.6% to $6.10. Fresh Vine Wine shares climbed 20% on Wednesday after the company reported a partnership with CRAVE American Kitchen & Sushi Bar.
  • Denali Therapeutics Inc. DNLI dropped 11.7% to $34.03. The FDA issued a clinical hold on Denali Therapeutics’ Investigational New Drug (IND) application for DNL919 TREM.
  • NEXGEL, Inc. NXGL fell 11.5% to $2.9018. NexGel shares gained around 12% on Wednesday after the company announced the launch of the MEDAGEL ClearComfort hydrogel patch.
  • GreenTree Hospitality Group Ltd. GHG fell 11.3% to $7.43 after the company posted results for the third quarter.
  • E2open Parent Holdings, Inc. ETWO dipped 10.4% to $8.69. E2open reported an adjusted gross profit of $103.4 million for the third quarter, up from $89.6 million in the year-ago period. Its non-GAAP revenue also climbed to $147.4 million from $129.5 million. E2open raised its FY22 adjusted sales guidance to $474 million to $476 million.
  • GrowGeneration Corp. GRWG fell 9.6% to $10.03 after the company issued weak sales forecast. GrowGeneration said it sees FY21 revenue of $420 million to $422 million.
  • OceanPal Inc. OP fell 8.6% to $2.02 after adding 13% on Wednesday.
  • Elastic N.V. ESTC dropped 8.4% to $101.69. The company announced the promotion of Ashutosh Kulkarni to CEO and gave an update on its Q3 guidance.
  • Novavax, Inc. NVAX dipped 7.7% to $120.34. Novavax's COVID-19 vaccine recently swung an OK in South Korea, where it will be manufactured and marketed by SK bioscience.
  • Vaxcyte, Inc. PCVX fell 7.7% to $20.31 after the company reported pricing of $100 million public offering.
  • Vaxxinity, Inc. VAXX shares fell 7% to $7.03. Vaxxinity shares jumped 30% on Wednesday after the company announced the first Parkinson's disease patient has been dosed in Part B of a Phase 1 clinical trial of UB-312..
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...